Skip to content
The Inflation Reduction Act (IRA) is expected to have broad negative impacts on patients, most notably through less access to future cures and treatments. […]
Heart disease patients and the IRA’s misguided incentives Read More »
The COVID-19 pandemic laid bare the vulnerabilities of global supply chains, especially in the biopharmaceutical sector. “Nobody ever could have envisioned a global pandemic
Why building America’s biomanufacturing sector is critical for America’s security Read More »
President Biden’s executive order announced March 18 calls for coordinated federal action and an investment of $200 million to promote research into women’s health,
Biden’s executive order on women’s health research includes $200M for NIH Read More »
Innovative biotech firms stand to gain from legislation that would help startups gain access to capital they need and spend more of that capital
House passes bill to help biotech startups build capital Read More »
During the State of the Union address on March 7, President Biden said, “Women are more than half of our population, but research on
BIO’s Women’s Health Task Force fosters greater innovation in women’s health Read More »
President Biden delivered his third State of the Union address last night, March 7. Health care was a prominent theme throughout the night, which
Key takeaways from the State of the Union address Read More »
On Monday, March 4, the White House will host a “listening session” on the impact of Pharmacy Benefit Managers (PBMs). This is a welcome
As White House prepares ‘listening session’ on PBMs, here’s what they need to hear Read More »
Bipartisan legislation to support research into rare diseases received backing from witnesses and lawmakers during a Feb. 29 hearing of the House Energy and
Lawmakers back bipartisan legislation supporting rare disease research Read More »
Biotechnology Innovation Organization (BIO) member companies and CEOs sent a letter to congressional leaders urging them to pass the bipartisan ORPHAN Cures Act and
CEOs ask Congress to pass ORPHAN Cures Act Read More »
The biotech industry must constantly navigate the ins and outs of Beltway politics. During an election year, the need to anticipate and plan for
What policy biotech should be watching this election year Read More »
